A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis.
Ontology highlight
ABSTRACT: Diagnosis of liver cirrhosis is essential in the management of chronic hepatitis C virus (HCV) infection. Liver biopsy is invasive and thus entails a risk of complications as well as a potential risk of sampling error. Therefore, non-invasive diagnostic tools are preferential. The aim of the present study was to create a model for accurate prediction of liver cirrhosis based on patient characteristics and biomarkers of liver fibrosis, including a panel of non-cholesterol sterols reflecting cholesterol synthesis and absorption and secretion. We evaluated variables with potential predictive significance for liver fibrosis in 278 patients originally included in a multicenter phase III treatment trial for chronic HCV infection. A stepwise multivariate logistic model selection was performed wit
SUBMITTER: Ydreborg M
PROVIDER: S-EPMC3974766 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA